Research coauthored by RTI Health Solutions researchers will be presented at the 2019 North American Neuroendocrine Tumor Society (NANETS) Conference.
Satisfaction Survey of administration modes for Long-Acting (LA) Somatostatin Analog (SSA) therapy in patients with Neuroendocrine Tumors (NET). Darden C, Ray D, Goldstein G, Goss D, Garbinsky D, Bennett L, Price M, Thota R.
XERMELO patient registry: improvements in clinical outcomes, patients satisfaction, and weight with telotristat ethyl in the real-world. Joish VN, Price MA, Schwartz S, Fish-Steagall A, Bennett L, Darden C, Tesfaye E, Arnold K, Wason S, Lapuerta P.